ALLO : Allogene Therapeutics stock forecast, predictions, and share price target for 2022, 2023 (1 year) to 2025 - 2027 (5 year) to 2030, and 2032 (10 year) with Revenue and EPS Prognosis by Technical Analysis
| year | Average | Low | High | Change from close on 2023-09-29 |
|---|---|---|---|---|
| 2023 | $3.15 | $3.15 | $3.16 | -0.53% |
| 2024 | $3.08 | $2.91 | $3.18 | -2.98% |
| 2025 | $2.73 | $2.64 | $2.88 | -13.74% |
| 2026 | $2.61 | $2.6 | $2.63 | -17.75% |
| 2027 | $2.62 | $2.6 | $2.71 | -17.5% |
| 2028 | $4.36 | $2.87 | $5.11 | 37.63% |
| 2029 | $5.16 | $5.02 | $5.34 | 62.8% |
| 2030 | $5.84 | $5.42 | $6.26 | 84.3% |
| 2031 | $6.57 | $6.32 | $6.74 | 107.11% |
| 2032 | $6.84 | $6.76 | $6.9 | 115.91% |
| 2033 | $6.93 | $6.91 | $6.95 | 118.57% |
The 19 Wall Street analysts offering Allogene Therapeutics stock forecast in the last 6 months have average price target of
$19.18 with a high forecast of $35.0 and a low forecast of $7.5.
The average Allogene Therapeutics stock forecast represents a 505.05%
increase from the last price of $3.17000007629395.
From AI system, total return is 2366.52% from 4098 forecasts.
For Allogene Therapeutics stock forecast for 2023, 3 predictions are offered for each month of 2023 with average Allogene Therapeutics stock
forecast of $3.15, a high forecast of $3.16, and a low forecast of $3.15.
The average Allogene Therapeutics stock forecast 2023 represents a -0.53%
decrease from the last price of $3.17000007629395.
For Allogene Therapeutics stock forecast for 2024, 12 predictions are offered for each month of 2024 with average Allogene Therapeutics stock
forecast of $3.08, a high forecast of $3.18, and a low forecast of $2.91.
The average Allogene Therapeutics stock forecast 2024 represents a -2.98%
decrease from the last price of $3.17000007629395.
For Allogene Therapeutics stock forecast for 2026, 12 predictions are offered for each month of 2026 with average Allogene Therapeutics stock
forecast of $2.61, a high forecast of $2.63, and a low forecast of $2.6.
The average Allogene Therapeutics stock forecast 2026 represents a -17.75%
decrease from the last price of $3.17000007629395.
For Allogene Therapeutics stock forecast for 2028 (5 year), 12 predictions are offered for each month of 2028 with average Allogene Therapeutics stock
forecast of $4.36, a high forecast of $5.11, and a low forecast of $2.87.
The average Allogene Therapeutics stock forecast 2028 represents a 37.63%
increase from the last price of $3.17000007629395.
For Allogene Therapeutics stock forecast for 2031, 12 predictions are offered for each month of 2031 with average Allogene Therapeutics stock
forecast of $6.57, a high forecast of $6.74, and a low forecast of $6.32.
The average Allogene Therapeutics stock forecast 2031 represents a 107.11%
increase from the last price of $3.17000007629395.
For Allogene Therapeutics stock forecast for 2033 (10 year), 9 predictions are offered for each month of 2033 with average Allogene Therapeutics stock
forecast of $6.93, a high forecast of $6.95, and a low forecast of $6.91.
The average Allogene Therapeutics stock forecast 2033 represents a 118.57%
increase from the last price of $3.17000007629395.
Please, see more forecasts below.
ALLO : Allogene Therapeutics stock forecast by Wall Street Analysts
The average Allogene Therapeutics stock forecast from last 6 month is $19.18, and this show a -16.67% decrease in average from the prior price target of the each prediction. Also, this average forecast of $19.18 represents a 4.75% increase from the past average forecast of $18.31, 6 months ago from 16 wall street analysts.
Allogene Therapeutics stock forecast for upcoming days
| Date | Price Target | Change |
|---|---|---|
| 2023-10-02 | $3.12 | -1.66% |
| 2023-10-03 | $3.06 | -1.98% |
| 2023-10-04 | $2.99 | -2.25% |
| 2023-10-05 | $2.91 | -2.60% |
| 2023-10-06 | $2.82 | -3.09% |
ALLO : Long term Allogene Therapeutics stock forecast for 2022, 2023 (1 year) - 2025 - 2027 (5 year) - 2030, and 2032 (10 year)
Forecast for 2023 Oct. is $3.15 , for 2024 Sep. is $3.02 , for 2027 Sep. is $2.61 , for 2028 Sep. is $4.95 , for 2032 Sep. is $6.88 , and for 2033 Sep. is $6.95.
ALLO : Allogene Therapeutics stock forecast for 2023
| Date | Price Target | Change |
|---|---|---|
| 2023 Oct. | $3.15 | -0.66% |
| 2023 Nov. | $3.15 | 0.02% |
| 2023 Dec. | $3.16 | 0.35% |
ALLO : Allogene Therapeutics stock forecast for 2024
| Date | Price Target | Change |
|---|---|---|
| 2024 Jan. | $3.17 | 0.35% |
| 2024 Feb. | $3.18 | 0.13% |
| 2024 Mar. | $3.17 | -0.17% |
| 2024 Apr. | $3.16 | -0.46% |
| 2024 May. | $3.13 | -0.68% |
| 2024 Jun. | $3.11 | -0.83% |
| 2024 Jul. | $3.08 | -0.91% |
| 2024 Aug. | $3.05 | -0.98% |
| 2024 Sep. | $3.02 | -1.07% |
| 2024 Oct. | $2.98 | -1.14% |
| 2024 Nov. | $2.95 | -1.18% |
| 2024 Dec. | $2.91 | -1.21% |
ALLO : Allogene Therapeutics stock forecast for 2025
| Date | Price Target | Change |
|---|---|---|
| 2025 Jan. | $2.88 | -1.22% |
| 2025 Feb. | $2.84 | -1.21% |
| 2025 Mar. | $2.81 | -1.17% |
| 2025 Apr. | $2.78 | -1.09% |
| 2025 May. | $2.75 | -0.98% |
| 2025 Jun. | $2.73 | -0.86% |
| 2025 Jul. | $2.71 | -0.74% |
| 2025 Aug. | $2.69 | -0.63% |
| 2025 Sep. | $2.68 | -0.54% |
| 2025 Oct. | $2.66 | -0.46% |
| 2025 Nov. | $2.65 | -0.40% |
| 2025 Dec. | $2.64 | -0.37% |
ALLO : Allogene Therapeutics stock forecast for 2026
| Date | Price Target | Change |
|---|---|---|
| 2026 Jan. | $2.63 | -0.34% |
| 2026 Feb. | $2.63 | -0.32% |
| 2026 Mar. | $2.62 | -0.28% |
| 2026 Apr. | $2.61 | -0.23% |
| 2026 May. | $2.61 | -0.17% |
| 2026 Jun. | $2.60 | -0.14% |
| 2026 Jul. | $2.60 | -0.11% |
| 2026 Aug. | $2.60 | -0.08% |
| 2026 Sep. | $2.60 | -0.06% |
| 2026 Oct. | $2.60 | -0.03% |
| 2026 Nov. | $2.60 | -0.02% |
| 2026 Dec. | $2.60 | -0.00% |
ALLO : Allogene Therapeutics stock forecast for 2027
| Date | Price Target | Change |
|---|---|---|
| 2027 Jan. | $2.60 | 0.00% |
| 2027 Feb. | $2.60 | 0.01% |
| 2027 Mar. | $2.60 | 0.01% |
| 2027 Apr. | $2.60 | 0.02% |
| 2027 May. | $2.60 | 0.03% |
| 2027 Jun. | $2.60 | 0.04% |
| 2027 Jul. | $2.60 | 0.07% |
| 2027 Aug. | $2.60 | 0.13% |
| 2027 Sep. | $2.61 | 0.24% |
| 2027 Oct. | $2.62 | 0.47% |
| 2027 Nov. | $2.65 | 1.02% |
| 2027 Dec. | $2.71 | 2.41% |
ALLO : Allogene Therapeutics stock forecast for 2028
| Date | Price Target | Change |
|---|---|---|
| 2028 Jan. | $2.87 | 5.64% |
| 2028 Feb. | $3.16 | 10.29% |
| 2028 Mar. | $3.57 | 12.78% |
| 2028 Apr. | $3.98 | 11.76% |
| 2028 May. | $4.35 | 9.28% |
| 2028 Jun. | $4.63 | 6.30% |
| 2028 Jul. | $4.79 | 3.52% |
| 2028 Aug. | $4.88 | 1.93% |
| 2028 Sep. | $4.95 | 1.32% |
| 2028 Oct. | $5.01 | 1.13% |
| 2028 Nov. | $5.06 | 1.05% |
| 2028 Dec. | $5.11 | 0.97% |
ALLO : Allogene Therapeutics stock forecast for 2029
| Date | Price Target | Change |
|---|---|---|
| 2029 Jan. | $5.15 | 0.88% |
| 2029 Feb. | $5.19 | 0.83% |
| 2029 Mar. | $5.24 | 0.80% |
| 2029 Apr. | $5.23 | -0.08% |
| 2029 May. | $5.14 | -1.76% |
| 2029 Jun. | $5.05 | -1.69% |
| 2029 Jul. | $5.02 | -0.62% |
| 2029 Aug. | $5.04 | 0.37% |
| 2029 Sep. | $5.10 | 1.08% |
| 2029 Oct. | $5.17 | 1.48% |
| 2029 Nov. | $5.25 | 1.62% |
| 2029 Dec. | $5.34 | 1.60% |
ALLO : Allogene Therapeutics stock forecast for 2030
| Date | Price Target | Change |
|---|---|---|
| 2030 Jan. | $5.42 | 1.52% |
| 2030 Feb. | $5.50 | 1.41% |
| 2030 Mar. | $5.57 | 1.32% |
| 2030 Apr. | $5.64 | 1.28% |
| 2030 May. | $5.71 | 1.29% |
| 2030 Jun. | $5.79 | 1.32% |
| 2030 Jul. | $5.87 | 1.45% |
| 2030 Aug. | $5.97 | 1.61% |
| 2030 Sep. | $6.06 | 1.50% |
| 2030 Oct. | $6.13 | 1.22% |
| 2030 Nov. | $6.20 | 1.11% |
| 2030 Dec. | $6.26 | 1.05% |
ALLO : Allogene Therapeutics stock forecast for 2031
| Date | Price Target | Change |
|---|---|---|
| 2031 Jan. | $6.32 | 0.99% |
| 2031 Feb. | $6.38 | 0.92% |
| 2031 Mar. | $6.44 | 0.85% |
| 2031 Apr. | $6.49 | 0.77% |
| 2031 May. | $6.53 | 0.68% |
| 2031 Jun. | $6.57 | 0.60% |
| 2031 Jul. | $6.60 | 0.52% |
| 2031 Aug. | $6.63 | 0.47% |
| 2031 Sep. | $6.66 | 0.43% |
| 2031 Oct. | $6.69 | 0.41% |
| 2031 Nov. | $6.72 | 0.39% |
| 2031 Dec. | $6.74 | 0.37% |
ALLO : Allogene Therapeutics stock forecast for 2032
| Date | Price Target | Change |
|---|---|---|
| 2032 Jan. | $6.76 | 0.33% |
| 2032 Feb. | $6.78 | 0.30% |
| 2032 Mar. | $6.80 | 0.27% |
| 2032 Apr. | $6.82 | 0.24% |
| 2032 May. | $6.83 | 0.21% |
| 2032 Jun. | $6.85 | 0.19% |
| 2032 Jul. | $6.86 | 0.17% |
| 2032 Aug. | $6.87 | 0.15% |
| 2032 Sep. | $6.88 | 0.14% |
| 2032 Oct. | $6.89 | 0.13% |
| 2032 Nov. | $6.89 | 0.12% |
| 2032 Dec. | $6.90 | 0.11% |
ALLO : Allogene Therapeutics stock forecast for 2033
| Date | Price Target | Change |
|---|---|---|
| 2033 Jan. | $6.91 | 0.10% |
| 2033 Feb. | $6.91 | 0.09% |
| 2033 Mar. | $6.92 | 0.08% |
| 2033 Apr. | $6.92 | 0.07% |
| 2033 May. | $6.93 | 0.07% |
| 2033 Jun. | $6.93 | 0.06% |
| 2033 Jul. | $6.94 | 0.06% |
| 2033 Aug. | $6.94 | 0.06% |
| 2033 Sep. | $6.95 | 0.05% |
Frequently Asked Questions about Allogene Therapeutics stock forecast
Is Allogene Therapeutics a good long term stock?
From Allogene Therapeutics stock forecast , Allogene Therapeutics (ALLO) stock cannot be a good investment choice. According to Tudal, the Allogene Therapeutics stock price forecast for 2023 Oct. is $3.149159226932 From Allogene Therapeutics stock forecast , Allogene Therapeutics (ALLO) stock cannot be a good investment choice. According to Tudal, the Allogene Therapeutics stock price forecast for 2024 Sep. is $3.01705759834754 From Allogene Therapeutics stock forecast , Allogene Therapeutics (ALLO) stock cannot be a good investment choice. According to Tudal, the Allogene Therapeutics stock price forecast for 2027 Sep. is $2.61038221140269 From Allogene Therapeutics stock forecast , Allogene Therapeutics (ALLO) stock can be a good investment choice. According to Tudal, the Allogene Therapeutics stock price forecast for 2028 Sep. is $4.94895875778984 From Allogene Therapeutics stock forecast , Allogene Therapeutics (ALLO) stock can be a good investment choice. According to Tudal, the Allogene Therapeutics stock price forecast for 2032 Sep. is $6.87736391450534 From Allogene Therapeutics stock forecast , Allogene Therapeutics (ALLO) stock can be a good investment choice. According to Tudal, the Allogene Therapeutics stock price forecast for 2033 Sep. is $6.94577018921905
Is Allogene Therapeutics stock overvalued?
Allogene Therapeutics (ALLO) stock is expected to go DOWN . Therefore, Tudal would say that Allogene Therapeutics (ALLO) stock is overvalued.
Will Allogene Therapeutics stock price go up?
No. The Allogene Therapeutics stock price forecast for 2024 Sep. is $3.01705759834754
Is Allogene Therapeutics stock a good buy now?
Since closing price on 2023-09-29 is $3.17000007629395 and forecast for 2024 Sep. is $3.02, Allogene Therapeutics stock is not a good 1 year investment.